People with Parkinson’s disease who stay active while in the hospital may recover faster and live longer, according to a study. The research, conducted by the Parkinson’s Foundation in partnership with University Hospitals, found that patients who moved at least three times a day — as the Parkinson’s…
More than 250 Parkinson’s patients, family members, scientists, and advocates gathered recently in Washington to urge Congress to expand federal funding for Parkinson’s disease research at the National Institutes of Health (NIH). They were part of the annual Parkinson’s Policy Forum, hosted by organizations including the Michael J. Fox…
Parkinson’s disease and essential tremor are associated with distinct signaling patterns of two key brain neurotransmitters, dopamine and serotonin, according to a new study. These two chemical messengers allow nerve cells to communicate. Using machine learning, researchers analyzed the regulation of neurotransmitter systems during reward-based decision-making, a cognitive process…
The American Parkinson Disease Association (APDA) is providing $4.04 million for the 2025-2026 funding year to support research projects on Parkinson’s disease. That represents an increase of more than 55% from last year, according to an association press release. Research areas receiving funding range from brain changes…
The Parkinson’s Foundation invites U.S. medical centers offering outstanding Parkinson’s disease clinical care and resources to join its Global Care Network as Centers of Excellence. Applications from academic medical centers in Delaware, Kentucky, Missouri, Nebraska, New Jersey, Ohio, Texas, and Washington will be given priority. Special consideration…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $697,000 grant to a research project using preclinical models to study early Parkinson’s disease linked to mutations in the PINK1 gene. Cynthia Kelm-Nelson, PhD, a department of surgery senior scientist, will lead the three-year project…
Noninvasively stimulating a nerve in the leg using Stimvia‘s URIS device is feasible, safe, and may help reduce motor symptoms and improve quality of life in people with Parkinson’s disease, according to new data from a pilot study. Indeed, among the small number of patients with tremor in…
The Parkinson’s Foundation has launched a pilot program it hopes will make it easier for Parkinson’s disease patients who carry specific disease-related genetic variants to enroll in clinical trials testing targeted experimental treatments. The new program, dubbed PD Trial Navigator, is designed to help meet a central goal of…
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $5 million grant to Congruence Therapeutics to advance the development of small molecules for Parkinson’s disease associated with mutations in the GBA1 gene. The research grant will support the optimization and clinical development of therapeutic candidates…
A five-year, $3.4 million grant from the National Institute of Environmental Health Sciences is supporting research into how manganese exposure may increase the risk of developing Parkinson’s disease. Manganese is an essential mineral the body needs in small amounts. However, high-level exposure, such as through certain pesticides, mining, or…
Get regular updates to your inbox.
